A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours-Reference-Cited by-同舟云学术

A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours

Published:2014-03 Issue:5 Volume:50 Page:876-884
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hollebecque Antoine,Houédé Nadine,Cohen Ezra E.W.,Massard Christophe,Italiano Antoine,Westwood Paul,Bumgardner William,Miller Joel,Brail Les H.,Benhadji Karim A.,Soria Jean-Charles

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. A complex interplay between Akt, TSC2 and the two mTOR complexes;Huang;Biochem Soc Trans,2009

2. TOR controls translation initiation and early G1 progression in yeast;Barbet;Mol Biol Cell,1996

3. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin;Brunn;Science,1997

4. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth;Dorrello;Science,2006

5. EIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation;Gingras;Annu Rev Biochem,1999

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma;Cancer Research Communications;2024-08-01

2. Discovery of novel S6K1 inhibitors by an ensemble-based virtual screening method and molecular dynamics simulation;Journal of Molecular Modeling;2023-03-18

3. 3,4-Diaminopyrazolo[3,4-d]pyrimidines: a new three-component microwave-assisted synthesis and anti-leukemic properties;Organic & Biomolecular Chemistry;2023

4. Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors;Cancers;2022-12-12

5. Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells;Nature Communications;2022-11-14